# CABAZITAXEL
> **NDA207937** · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2019-11-22
## Drug
- **FDA Application Number:** NDA207937
- **Application type:** New Drug Application
- **Brand name:** CABAZITAXEL
- **Generic name:** Cabazitaxel
- **Active ingredients:** CABAZITAXEL
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** FRESENIUS KABI USA
- **First approval:** 2019-11-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207937)
---
*AI Analytics · CC0 1.0*